CTRI/2025/11/097227尚未招募不适用
Efficacy of RUSH protocol in early recognition of shock in emergency medicine: A Prospective observational study
Dr Pranavi Lokineni1 个研究点 分布在 1 个国家目标入组 37 人开始时间: 2025年11月25日最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 37
- 试验地点
- 1
- 主要终点
- To evaluate the effectiveness of the RUSH protocol in rapidly differentiating the type of shock.
研究概览
简要总结
Primary purpose:
· To evaluate the effectiveness of the RUSH protocol in rapidly differentiating the type of shock.
H****ypothesis:
RUSH protocol may be effective in rapidly differentiating type of shock in emergency department
hy
h
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18.00 Year(s) 至 99.00 Year(s)（—）
- 性别
- All
入选标准
- •adult patients presenting to emergency department in shock.
排除标准
- •• Patients with known cause (With final diagnosis, Gastrointestinal bleeding) Patients who have received treatment from outside hospital.
- •Patients in cardio pulmonary arrest and post CPR.
- •Pregnant females.
- •Patients not willing to participate.
结局指标
主要结局
To evaluate the effectiveness of the RUSH protocol in rapidly differentiating the type of shock.
时间窗: 18months
次要结局
- To find the incidence of various types of shock in Emergency department.(18months)
研究者
Dr Pranavi Lokineni
DATTA MEGHE INSTITUTE OF HIGHER EDUCATION AND RESEARCH
研究点 (1)
Loading locations...
相似试验
招募中
不适用
Research on Early Screening and Diagnosis of Pulmonary Nodules Based on Novel Non-invasive Technologies.Lung CancerNCT07370077Chen KeZhong1,800
尚未招募
不适用
Which Rapid Sequence Induction Technique Should be Used in Urgent Surgery in Children?NCT07428434Tunis University100
尚未招募
不适用
Smartphone-enabled Hybrid Identification of Early CoLorectal Disease Using Blood-Based Cancer Testing Across TeXasNCT07398456Baylor Research Institute5,500
招募中
不适用
In Vivo Evaluation of the Accuracy of Immediate Screw-Retained Provisional Crowns Fabricated Using Digital Planning and Guided SurgeryNCT07315607Universidad Complutense de Madrid27
招募中
2 期
A clinical study of new treatments for non-small cell lung cancer (MK-3475-01J)2025-521939-36-00Merck Sharp & Dohme LLC9